ContraFect Reports Second Quarter 2022 Financial Results and Provides Corporate Update
YONKERS, N.Y., Aug. 15, 2022 -- ContraFect Corporation , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents , including lysins and amurin... | August 15, 2022
Cara Cassino Garrett Nichols Michael Messinger Rogerj Pomerantz European Congress Contrafect Corporation
Source: marketscreener.com